Skip to main content
Fig. 3 | BMC Medical Genomics

Fig. 3

From: Glycosyltransferase GLT8D1 and GLT8D2 serve as potential prognostic biomarkers correlated with Tumor Immunity in Gastric Cancer

Fig. 3

Prognostic and diagnostic value of GLT8D1/2 in gastric cancer. (A) Univariate and multivariate Cox regression analyses of GLT8D1/2 mRNA expression associated with OS prognosis in gastric cancer with different clinicopathological characteristics. Red squares indicate HR, HR > 1 with 95% CI greater than 1 indicates disadvantageous factors, and HR < 1 with 95% CI lower than 1 indicates protective factors. (B) The prognostic nomograms. (C) The calibration plot evaluated and verified the prediction accuracy of the prognostic nomogram. (D) The diagnostic value of GLT8D1/2 expression was evaluated using the ROC curves. The AUC value ranges between 0.5 (random-quality prediction) and 1 (perfect prediction), and the AUC value closer to 1, indicates a more accurate diagnostic model. ROC, receiver operating characteristic; AUC, area under ROC curve; HR, hazard ratio; FPR, false positive rate; TPR, true positive rate

Back to article page